Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.410
-0.170 (-10.76%)
At close: Nov 16, 2026, 4:00 PM EST
1.428
+0.018 (1.29%)
After-hours: Nov 16, 2026, 7:06 PM EST
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $168.65 million as of November 16, 2026. It is the 21,390th most valuable company in the world and the 3,637th biggest in the United States. Its market cap has decreased by 37.88% in one year.
Market Cap
168.65M
Enterprise Value
130.48M
1-Year Change
-37.88%
Global Rank
Country Rank
#3,637 United States
Category
ChartMarket Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $168.65M, a decrease of -67.80%. That is a compound annual growth rate of -19.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 168.65M | 135.53% |
| Dec 31, 2025 | 71.60M | -22.81% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sol-Gel Technologies | 179.94M |
| Whitehawk Therapeutics | 177.62M |
| Korro Bio | 174.45M |
| InflaRx | 173.89M |
| Alpha Cognition | 170.52M |
| AN2 Therapeutics | 169.61M |
| Oramed Pharmaceuticals | 169.60M |
| Eledon Pharmaceuticals | 166.54M |